India to Kenya: Carfilzomib Export Trade Route

The India to Kenya Carfilzomib corridor is one of India's established pharmaceutical export routes, with 22 shipments documented worth a combined $32.2K USD. The route is dominated by R S SURGIPHARM PRIVATE LIMITED, which alone accounts for roughly 24% of all export value, reflecting the consolidated nature of India's carfilzomib manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $1.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with carfilzomib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 29.6%, placing it at rank #16 among India's top carfilzomib export destinations globally.

On the import side, key buyers of Indian carfilzomib in Kenya include TO, TO THE ORDER OF INVOICE RAISED TO, TO THE ORDER and 6 others. TO is the single largest importer with 8 shipments valued at $11.7K USD.

India's carfilzomib exports to Kenya are driven primarily by a handful of large-scale manufacturers. R S SURGIPHARM PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED, ASPIRA BIOHEALTH LLP — together account for 70% of total trade value on this route. The average shipment value of $1.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines injecatable and tablets carfilzomib for injection 60mg 1 vial and (harmless medicines for injectable and capsules and tablets) carfilzomib for injection 60mg (1 vial), suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO is the largest importer with 8 shipments worth $11.7K USD — representing 36% of all carfilzomib imports from India on this route. A total of 9 buyers are active on this corridor.